Table 11.12

Adjusted Patient Survival, Heart Transplants

Survival at 3 Months, 1 Year, 3 Years, and 5 Years

  3 Months 1 Year 3 Years 5 Years
(Tx 2003 - 2004) (Tx 2003 - 2004) (Tx 2001 - 2004) (Tx 1999 - 2004)
N % Std. Err. N % Std. Err. N % Std. Err. N % Std. Err.
Total All 3,851 92.5% 0.4% 3,851 88.1% 0.5% 7,996 80.1% 0.5% 12,154 73.5% 0.5%
Primary Diagnosis Coronary Artery Disease 1,573 91.7% 0.7% 1,573 87.4% 0.9% 3,353 79.7% 0.9% 5,236 72.7% 0.8%
Cardiomyopathy 1,858 94.7% 0.5% 1,858 90.8% 0.7% 3,759 82.4% 0.7% 5,666 76.1% 0.7%
Congenital Heart Disease 330 83.9% 2.7% 330 75.5% 3.3% 671 69.7% 2.5% 935 63.0% 2.5%
Valvular Heart Disease 78 91.8% 3.0% 78 89.5% 3.3% 179 77.7% 3.4% 270 70.4% 3.4%
Other 12 75.9% 11.5% 12 75.9% 11.5% 33 74.6% 7.7% 45 54.1% 11.4%
Unknown 0 - - 0 - - 1 0.0% 0.0% 2 41.4% 24.6%


Source: OPTN/SRTR Data as of May 1, 2006.

(+) = Values not determined due to insufficient follow-up. (-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Patient survival follows patients from first transplant of this type until death. Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on heart and heart-lung transplants.

Multi-organ transplants are excluded.

Survival rates are adjusted to the characteristics of the 3 month and 1 year cohort. See Technical Notes for details.